Table 3. Rate ratios for incidence of total prostate cancer and its subtypes by levels of BMI at age 30 years in the cohort of 36 959 Swedish men aged 45–79 years.
BMI at age 30 years (reference point), kg m–2 |
|||||||
---|---|---|---|---|---|---|---|
<21 (18) | 21–22.9 (22) | 23–24.9 (24) | 25–27.4 (26.25) | 27.5–29.9 (28.75) | ⩾30 (35) | For every 5 kg m–2 BMI increase | |
Localised prostate cancer | |||||||
Age-adjusted model | |||||||
No. of cases/person-years | 290/67 977 | 550/120 481 | 472/116 166 | 161/49 565 | 42/11 629 | 15/5975 | |
RR (95% CI)a | 1.01 (0.92–1.12) | 1 | 0.99 (0.94–1.04) | 0.99 (0.89–1.10) | 0.98 (0.83–1.16) | 0.96 (0.69–1.32) | 0.98 (0.87–1.11) |
Multivariable modelb | |||||||
No. of cases/person-years | 287/66 730 | 539/117 845 | 467/113 617 | 154/48 573 | 41/11 308 | 15/5800 | |
RR (95% CI)a | 1.01 (0.91–1.12) | 1 | 0.99 (0.94–1.05) | 0.99 (0.89–1.10) | 0.98 (0.82–1.16) | 0.96 (0.69–1.34) | 0.98 (0.87–1.12) |
RR (95% CI)a,c | 1.03 (0.93–1.14) | 1 | 0.99 (0.94–1.04) | 0.97 (0.87–1.08) | 0.96 (0.81–1.14) | 0.92 (0.66–1.28) | 0.97 (0.85–1.10) |
Advanced prostate cancer | |||||||
Age-adjusted model | |||||||
No. of cases/person-years | 112/67 977 | 192/120 481 | 166/116 166 | 70/49 565 | 9/11 629 | 5/5975 | |
RR (95% CI)a | 1.09 (0.93–1.28) | 1 | 0.96 (0.88–1.04) | 0.91 (0.77–1.08) | 0.87 (0.66–1.14) | 0.76 (0.45–1.28) | 0.90 (0.73–1.10) |
Multivariable modelb | |||||||
No. of cases/person-years | 108/66 730 | 185/117 845 | 164/113 617 | 69/48 573 | 8/11 308 | 4/5800 | |
RR (95% CI)a | 1.09 (0.92–1.29) | 1 | 0.96 (0.88–1.04) | 0.91 (0.77–1.09) | 0.87 (0.65–1.15) | 0.76 (0.44–1.30) | 0.90 (0.73–1.11) |
RR (95% CI)a,c | 1.11 (0.94–1.31) | 1 | 0.95 (0.87–1.03) | 0.90 (0.75–1.07) | 0.84 (0.63–1.11) | 0.71 (0.41–1.23) | 0.88 (0.71–1.08) |
Fatal prostate cancer | |||||||
Age-adjusted model | |||||||
No. of cases/person-years | 50/64 052 | 78/113 654 | 69/109 099 | 22/46 355 | 4/10 879 | 2/5553 | |
RR (95% CI)a | 1.31 (1.02–1.701) | 1 | 0.87 (0.77–0.99) | 0.75 (0.57–0.98) | 0.63 (0.41–0.97) | 0.41 (0.18–0.94) | 0.71 (0.52–0.98) |
Multivariable modelb | |||||||
No. of cases/person-years | 49/62 868 | 75/111 148 | 68/106 729 | 22/45 419 | 3/10 579 | 2/5384 | |
RR (95% CI)a | 1.28 (0.99–1.67) | 1 | 0.88 (0.77–1.01) | 0.77 (0.58–1.02) | 0.66 (0.42–1.03) | 0.45 (0.19–1.05) | 0.73 (0.53–1.02) |
RR (95% CI)a,c | 1.30 (1.00–1.71) | 1 | 0.88 (0.77–1.00) | 0.75 (0.57–1.01) | 0.64 (0.41–1.01) | 0.42 (0.18–1.02) | 0.72 (0.51–1.01) |
Abbreviations: CI=confidence interval; RR=rate ratio; BMI=body mass index.
The RRs and 95% CIs were calculated in correspondence with the reference points.
Multivariable RRs were adjusted for BMI at age 30 years (kg m–2), age at baseline (years), total energy intake (kcal), total physical activity (<37.9, 38–40.9, 41–44.9, ⩾45MET-h per day or missing), years of education (1–9, 9–12 or >12 years), smoking status (current, former or never smoker), family history of prostate cancer (yes, no or don’t know) and personal history of diabetes (yes or no).
RRs and 95% CIs calculated using competing-risks analysis. All the deaths from other causes than PCa were considered as competing events.